Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels ; volume:6 ; number:2 ; day:15 ; month:4 ; year:2014 ; pages:1-8 ; date:4.2014
Alzheimer's research & therapy ; 6, Heft 2 (15.4.2014), 1-8, 4.2014
- Creator
-
Wesnes, Keith A.
- Contributor
- DOI
-
10.1186/alzrt250
- URN
-
urn:nbn:de:1111-2016073131698
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wesnes, Keith A.
- Annas, Peter
- Basun, Hans
- Edgar, Chris
- Blennow, Kaj
- SpringerLink (Online service)
Other Objects (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial